Dopaminergic imaging in degenerative parkinsonisms, an established clinical diagnostic tool

N Nicastro, U Nencha, PR Burkhard… - Journal of …, 2023 - Wiley Online Library
Parkinson's disease (PD) and other neurodegenerative parkinsonisms are characterised by
loss of striatal dopaminergic neurons. Dopamine functional deficits can be measured in vivo …

Low clinical sensitivity and unexpectedly high incidence for neuropathologically diagnosed progressive supranuclear palsy

ED Driver-Dunckley, N Zhang… - … of Neuropathology & …, 2023 - academic.oup.com
The objective of this study was to determine the prevalence, incidence, and clinical
diagnostic accuracy for neuropathologically diagnosed progressive supranuclear palsy …

Clinical phenotypes of progressive supranuclear palsy—the differences in interleukin patterns

N Madetko-Alster, D Otto-Ślusarczyk… - International Journal of …, 2023 - mdpi.com
Progressive supranuclear palsy (PSP) is an atypical parkinsonian syndrome based on tau
pathology; its clinical phenotype differs, but PSP with Richardson's syndrome (PSP-RS) and …

Multimodality imaging of neurodegenerative disorders with a focus on multiparametric magnetic resonance and molecular imaging

JR Loftus, S Puri, SP Meyers - Insights Into Imaging, 2023 - Springer
Neurodegenerative diseases afflict a large number of persons worldwide, with the
prevalence and incidence of dementia rapidly increasing. Despite their prevalence, clinical …

Using Downgaze Palsy Progression Rate to Model Survival in Progressive Supranuclear Palsy–Richardson Syndrome

T Xie, AM Wills, C Liao, ML Dale… - Movement …, 2023 - Wiley Online Library
Background Rapid development of downgaze palsy, the most specific symptom of
progressive supranuclear palsy (PSP), has been associated with shorter survival in small …

[HTML][HTML] Utilizing speech analysis to differentiate progressive supranuclear palsy from Parkinson's disease

K Kang, AS Nunes, M Sharma, AJ Hall… - Parkinsonism & Related …, 2023 - Elsevier
Abstract Introduction Distinguishing Parkinson's disease (PD) from Progressive
supranuclear palsy (PSP) at early disease stages is important for clinical trial enrollment and …

Striatal dopamine transporter binding differs between dementia with Lewy bodies and Parkinson's disease with dementia

K Ishizawa, Y Fujita, K Nagashima, T Nakamura… - Journal of the …, 2023 - Elsevier
Abstract 123 I-ioflupane single-photon emission computed tomography (SPECT) is a highly
sensitive and established neuroimaging technique for parkinsonian syndromes (PS) …

Training high level balance and stepping responses in atypical progressive supranuclear palsy: a case report

E Croarkin, K Robinson, CJ Stanley… - … theory and practice, 2023 - Taylor & Francis
Background Progressive supranuclear palsy (PSP) is a neurodegenerative condition,
typically presenting with, but not limited to, impairments of postural instability, gait, and gaze …

Epidemiologia das síndromes parkinsonianas em idosos do sul do Brasil: estudo observacional de base populacional

GM Pereira - 2023 - lume.ufrgs.br
INTRODUÇÃO: A doença de Parkinson (DP) apresenta distribuição universal, incluindo
todos os grupos étnicos e socioeconômicos, como um distúrbio neurodegenerativo …